Licochalcone A inhibits the formation and bone resorptive activity of osteoclasts

被引:24
|
作者
Kim, Soon Nam [1 ,2 ]
Kim, Myung Hee [1 ,3 ]
Min, Yong Ki [1 ]
Kim, Seong Hwan [1 ]
机构
[1] Korea Res Inst Chem Technol, Lab Chem Gen, Taejon 305600, South Korea
[2] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea
[3] Chungnam Natl Univ, Dept Biochem, Taejon 305764, South Korea
关键词
Licochalcone A; Osteoclast formation; Bone resorption; ERK; NF-kappa B; Fra-2;
D O I
10.1016/j.cellbi.2008.04.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Licochalcone A on the formation and bone resorptive activity of osteoclasts up to 5 mu M significantly inhibited the receptor activator of nuclear factor kappa B (NF-kappa B) ligand ( RANKL)-induced activity of tartrate-resistant acid phosphatase (TRAP) activity and formation of osteoclasts without any effect on cell viability. Interestingly, licochalcone A was shown to inhibit the RANKL-induced activation of extracellular signal-regulated kinase, translocation of NF-kappa B into nucleus and mRNA expression of Fra-2. Licochalcone A also inhibited the bone resorptive activity of mature osteoclasts and the expression of bone resorption-related genes. Inhibitory effects of licochalcone A on the formation and bone resorptive activity of mouse bone marrow macrophage-derived osteoclasts were also observed. In conclusion, licochalcone A has the potential to inhibit the formation of osteoclasts as well as the bone resorptive activity of mature osteoclasts. (C) 2008 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1064 / 1072
页数:9
相关论文
共 50 条
  • [31] Inhibitory effects of SCOH, a novel compound, on differentiation and resorptive activity of osteoclasts.
    Lee, Z
    Ha, H
    Kwak, H
    Kim, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S351 - S351
  • [32] Large and small osteoclasts differ in resorptive activity and pH regulatory mechanisms.
    Lees, RL
    Sabharwal, VK
    Grinstein, S
    Heersche, JNM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S246 - S246
  • [33] Osteoclasts Lacking Rac2 Have Defective Chemotaxis and Resorptive Activity
    Itokowa, Takashi
    Zhu, Mei-ling
    Troiano, Nancy
    Bian, Jessica
    Kawano, Tustomu
    Insogna, Karl
    CALCIFIED TISSUE INTERNATIONAL, 2011, 88 (01) : 75 - 86
  • [34] NFATc1 mediates the stimulatory effects of post-translationally modified bone sialoprotein on the resorptive activity of rabbit osteoclasts
    Chen, H. H.
    Gordon, J. A. R.
    Pereverzev, A.
    Sims, S. M.
    Hunter, G. K.
    Dixon, S. J.
    Goldberg, H. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S255 - S255
  • [35] FORMATION OF LARGE OSTEOCLASTS IN BONE CULTURE
    LISKOVA, M
    JEAN, P
    UNION MEDICALE DU CANADA, 1972, 101 (04): : 745 - &
  • [36] Osteoclasts and Remodeling Based Bone Formation
    Kylmaoja, Elina
    Nakamura, Miho
    Tuukkanen, Juha
    CURRENT STEM CELL RESEARCH & THERAPY, 2016, 11 (08) : 626 - 633
  • [37] Rosuvastatin inhibits protein prenylation in osteoclasts and inhibits bone resorption in vitro
    Hughes, A
    Rogers, MJ
    Crockett, JC
    BONE, 2004, 34 : S21 - S21
  • [38] The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human Osteoclasts
    de Vries, Teun J.
    Mullender, Margriet G.
    van Duin, Marion A.
    Semeins, Cornelis M.
    James, Neil
    Green, Tim P.
    Everts, Vincent
    Klein-Nulend, Jenneke
    MOLECULAR CANCER RESEARCH, 2009, 7 (04) : 476 - 488
  • [39] Ceramide inhibits formation of F-actin ring in and bone resorption by mature osteoclasts.
    Takeda, H
    Ozaki, K
    Kitano, S
    Hanazawa, S
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 722 - 722